Recombinant Mycoplasma pneumoniae Uncharacterized protein MG284 homolog (MPN_403)

Shipped with Ice Packs
In Stock

Description

Overview of Uncharacterized Proteins in Mycoplasma pneumoniae

Uncharacterized proteins in M. pneumoniae are hypothetical gene products with limited functional annotation. These proteins are often studied for their roles in pathogenesis, antigenic variation, or metabolic adaptation. For example:

  • MPN_421: A homolog of MG294 involved in adhesion and immune evasion .

  • MPN_405: A homolog of MG286, recombinantly expressed in E. coli with a His tag for structural studies .

  • MPN_337: A homolog of MG241, featuring transmembrane domains and potential roles in host-pathogen interactions .

Recombinant Production and Applications

Recombinant mycoplasma proteins are typically produced in E. coli systems for research purposes. For instance:

  • MPN_405: Purified via heparin Sepharose chromatography, achieving >90% purity .

  • MPN_641: Expressed in E. coli, yeast, or mammalian cells for vaccine development .

  • RecA homologs: Demonstrated ATP-dependent DNA recombination activity critical for antigenic variation in adhesins like P1 and MgPa .

Research Gaps and Challenges

While several uncharacterized proteins have been studied, MPN_403 lacks direct experimental data in the literature. Key challenges include:

  • Functional annotation: Requires knockout studies or structural analysis (e.g., cryo-EM).

  • Antigenic potential: Surface-exposed domains may serve as vaccine candidates .

  • Role in pathogenesis: Possible involvement in immune evasion or metabolic pathways .

Future Directions

  1. Proteomic studies: Utilize mass spectrometry to identify MPN_403 expression during infection.

  2. Structural biology: Resolve 3D structures to predict ligand-binding sites.

  3. Host interaction assays: Test recombinant MPN_403 for immunogenicity or cytotoxicity.

Product Specs

Form
Lyophilized powder. We will ship the format we have in stock. If you have special format requirements, please note them when ordering.
Lead Time
Delivery time varies based on purchasing method and location. Consult your local distributor for specific delivery times. All proteins are shipped with blue ice packs by default. Contact us in advance for dry ice shipping (extra fees apply).
Notes
Avoid repeated freezing and thawing. Working aliquots can be stored at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute protein in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer ingredients, storage temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
MPN_403; F11_orf122a; MP435; Uncharacterized protein MG284 homolog
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-122
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Mycoplasma pneumoniae (strain ATCC 29342 / M129)
Target Names
MPN_403
Target Protein Sequence
MSFKVKNQSK HLYSLMTKFK RSQLILKHQS NNFASELWNE EDIIRSKQFI ELIEDTLLHL KKDTVDFIYD IFIYGKKPCD ISYSNSTYYK KLNKAANSFF DHFVWEAPIY KTKELKNDNS HS
Uniprot No.

Q&A

What is Mycoplasma pneumoniae MPN_403 and why is it significant in research?

MPN_403 is an uncharacterized protein in Mycoplasma pneumoniae, a fastidious bacterial pathogen that is a leading cause of community-acquired pneumonia. The significance of studying this protein relates to M. pneumoniae's clinical importance as a respiratory pathogen. According to recent epidemiological data, M. pneumoniae infections showed a resurgence in 2023 after a decline during the COVID-19 pandemic, particularly affecting pediatric populations in urban areas . Understanding uncharacterized proteins like MPN_403 may provide insights into M. pneumoniae's pathogenicity mechanisms and potential therapeutic targets.

How does MPN_403 relate to other characterized proteins in M. pneumoniae?

While specific data on MPN_403 is limited in the provided search results, we can draw parallels with other uncharacterized proteins in M. pneumoniae. Similar to other recombinant M. pneumoniae proteins, MPN_403 likely requires expression systems involving transfection of E. coli cells with a DNA expression vector containing the gene encoding the protein of interest . Comparative analysis with other M. pneumoniae proteins might reveal functional relationships or involvement in similar pathways, particularly in relation to pathogenesis mechanisms.

What detection methods are available for identifying MPN_403 in clinical or research samples?

Detection of M. pneumoniae proteins, including MPN_403, can be accomplished through several methodologies:

MethodAdvantagesLimitationsBest Application
PCR-based assaysHigh sensitivity and specificity; gold standardRequires specialized equipmentDefinitive detection
Serological antibody testingDetects immune response; widely availableCannot distinguish active from past infectionPopulation studies
Rapid antigen detectionFast results; minimal equipment needsLower sensitivity than PCREarly screening
Culture100% specific when positiveSlow (up to 3 weeks); insensitiveResearch confirmation

Polymerase chain reaction (PCR) remains the gold standard for M. pneumoniae detection, with P1 adhesin gene primers showing higher sensitivity than 16S rRNA primers . For protein-specific detection, antibody-based methods targeting MPN_403 would be necessary.

What expression systems are most effective for producing recombinant MPN_403 protein?

Based on approaches used for similar M. pneumoniae proteins, E. coli expression systems are commonly employed for recombinant production. The expression process typically involves:

  • Cloning the MPN_403 gene into an expression vector with appropriate tags (e.g., N-terminal His-tag)

  • Transforming E. coli cells with the expression vector

  • Inducing protein expression under optimized conditions

  • Collecting and purifying the protein through affinity purification

As observed with other M. pneumoniae recombinant proteins, purification typically achieves >85% purity as measured by SDS-PAGE . Expression systems may include fusion tags (such as 10xHis or Myc tags) to facilitate purification and detection, similar to what has been used for other M. pneumoniae uncharacterized proteins .

How can researchers differentiate between the function of MPN_403 and other related proteins?

Differentiating functional roles requires multiple complementary approaches:

  • Comparative genomic analysis: Identify unique sequence features of MPN_403 compared to homologous proteins

  • Protein-protein interaction studies: Determine specific binding partners unique to MPN_403

  • Gene knockout or knockdown experiments: Assess phenotypic changes specific to MPN_403 disruption

  • Domain-specific mutagenesis: Target unique domains to determine their contribution to function

  • Heterologous expression studies: Express MPN_403 in different backgrounds to assess function

These approaches should be conducted with appropriate controls, including parallel studies with related proteins to identify unique versus shared functions.

What bioinformatic approaches can predict potential functions of MPN_403?

Bioinformatic prediction methods can provide insights into potential functions:

  • Sequence homology analysis: Compare with functionally characterized proteins across species

  • Structural prediction: Generate 3D models using homology modeling or ab initio approaches

  • Domain and motif identification: Search for functional domains using databases like Pfam or InterPro

  • Gene neighborhood analysis: Examine genomic context for functional associations

  • Co-expression network analysis: Identify proteins with similar expression patterns

These computational predictions should guide experimental design but must be validated through wet-lab approaches.

What are the optimal PCR conditions for detecting the MPN_403 gene?

Based on PCR methodologies developed for M. pneumoniae detection, the following parameters are recommended:

ParameterRecommendationNotes
PCR TypeReal-time quantitative PCRMore sensitive than conventional PCR
Target RegionGene-specific unique sequencesAvoid regions with homology to other genes
Primer Design18-25 nucleotides, 40-60% GC contentCheck for secondary structures
Cycling ConditionsInitial denaturation: 95°C, 10 min
35-40 cycles: 95°C (15s), 55-60°C (30s), 72°C (30s)
Optimize annealing temperature
ControlsPositive, negative, no-template controlsInclude internal amplification control
Detection ChemistrySYBR Green or specific probesProbes increase specificity

For enhanced sensitivity, nested PCR approaches have shown superior detection rates for M. pneumoniae, though with increased contamination risk . New detection platforms like MP-RPA-CRISPR allow for rapid, simple, and accurate diagnosis at optimal reaction temperatures of 37°C .

How should researchers approach protein interaction studies involving MPN_403?

A systematic approach to protein interaction studies would include:

  • Co-immunoprecipitation (Co-IP): Using antibodies against MPN_403 to pull down interacting partners

  • Yeast two-hybrid screening: Using MPN_403 as bait to identify potential interactors

  • Proximity labeling: Using BioID or similar approaches to identify proteins in close proximity in vivo

  • Protein crosslinking: Capturing transient interactions through chemical crosslinking

  • Surface plasmon resonance: Measuring direct binding kinetics with purified proteins

Validation of potential interactions should be performed using multiple orthogonal methods and appropriate controls to distinguish specific from non-specific interactions.

What are the best practices for generating and validating antibodies against MPN_403?

Generating specific antibodies against MPN_403 requires:

  • Antigen design:

    • Use full-length recombinant protein if soluble

    • Alternatively, select unique peptide regions with high predicted antigenicity

    • Avoid regions with high homology to other proteins

  • Antibody production options:

    • Polyclonal antibodies: Recognize multiple epitopes but may have higher cross-reactivity

    • Monoclonal antibodies: Higher specificity but more resource-intensive

  • Validation protocols:

    • Western blot against recombinant MPN_403 and M. pneumoniae lysates

    • Testing against lysates from organisms lacking MPN_403

    • Pre-absorption controls with purified antigen

How should researchers interpret contradictory results between different detection methods for MPN_403?

When facing contradictory results between different detection methods:

  • Consider method sensitivity differences:

    • PCR methods typically have higher sensitivity than protein-based detection methods

    • Different PCR assays may have different detection limits

  • Evaluate specificity considerations:

    • Cross-reactivity with homologous proteins

    • Antibody specificity issues, especially with polyclonal antibodies

    • Primer binding to similar sequences in other organisms

  • Implement systematic troubleshooting:

    • Confirm results with additional, orthogonal methods

    • Include appropriate positive and negative controls

    • Consider sequence verification of PCR products

The challenge of interpreting contradictory results is particularly relevant for M. pneumoniae detection, as this fastidious bacterium can be difficult to culture, with a considerable seropositivity rate in the population and the possibility of transient asymptomatic carriage .

What experimental designs are most appropriate for studying the expression of MPN_403 under different conditions?

Optimal experimental designs include:

  • Time-course experiments:

    • Sample at multiple time points during growth or infection

    • Use appropriate normalization controls

    • Include biological and technical replicates

  • Comparative expression analysis:

    • Compare expression across different strains or clinical isolates

    • Correlate expression with virulence or other phenotypes

    • Use multiple detection methods (qPCR, Western blot)

  • Environmental response studies:

    • Test expression under different stress conditions

    • Examine host-pathogen interaction models

    • Consider in vivo vs. in vitro expression

When communicating research findings about MPN_403 expression, researchers should consider the preferences of past study participants (PSPs) who want to receive information about research findings but seldom do . Engaging both researchers and PSPs in the design of communication strategies can improve participant recruitment, enhance the use of research findings, and build community support for research .

How can researchers effectively compare MPN_403 function across different M. pneumoniae strains?

Comparative functional analysis should include:

  • Sequence comparison: Identify strain-specific variations in the MPN_403 gene

  • Expression analysis: Quantify expression levels across strains using qRT-PCR or proteomics

  • Functional assays: Develop assays to measure specific activities associated with MPN_403

  • Clinical correlation: Associate strain variations with clinical outcomes or virulence

  • Complementation studies: Test if MPN_403 from one strain can complement function in another

This comparative approach is particularly relevant given the emergence of macrolide-resistant M. pneumoniae strains, especially in East Asia, where up to 87% of pediatric M. pneumoniae infections are due to resistant strains . Understanding protein function across strains may provide insights into resistance mechanisms or virulence differences.

How might understanding MPN_403 function contribute to diagnostic or therapeutic approaches for M. pneumoniae infections?

Potential translational applications include:

  • Diagnostic development:

    • If MPN_403 is consistently expressed during infection, it could serve as a diagnostic biomarker

    • Protein-based rapid tests targeting MPN_403 could complement nucleic acid testing

  • Therapeutic target identification:

    • If MPN_403 plays a role in pathogenesis or antibiotic resistance, it could be a drug target

    • Structure-based drug design approaches could identify inhibitors of MPN_403 function

  • Vaccine development:

    • If MPN_403 is surface-exposed and immunogenic, it could be evaluated as a vaccine component

    • Conserved epitopes across strains would be particularly valuable

Recent outbreaks of M. pneumoniae, particularly the 2023 resurgence in pediatric populations, highlight the need for improved diagnostic and therapeutic approaches . The cyclical nature of M. pneumoniae outbreaks underscores the importance of continuous surveillance and research into potential virulence factors and therapeutic targets .

What are the considerations for studying MPN_403 in relation to macrolide resistance in M. pneumoniae?

Key considerations include:

  • Comparative expression analysis:

    • Compare MPN_403 expression between macrolide-sensitive and resistant strains

    • Determine if expression changes in response to macrolide exposure

  • Functional relationship assessment:

    • Investigate potential interactions between MPN_403 and known resistance determinants

    • Examine genomic context of MPN_403 relative to resistance genes

  • Clinical correlation studies:

    • Analyze MPN_403 sequence or expression in relation to treatment outcomes

    • Consider geographic variations in resistance patterns

The rising prevalence of macrolide-resistant M. pneumoniae, particularly in China, necessitates improved understanding of all potential factors contributing to resistance . While macrolides remain the preferred treatment for children with M. pneumoniae pneumonia, the increasing resistance rates highlight the need for alternative approaches .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.